16 Nov 2015 08:51
Thu, 26th May 2016 13:35
(ShareCast News) - Advanced Oncotherapy said two of its modules were ready for high power testing. The AIM listed proton therapy cancer treatment developer's shares fell by 3.33% to 7.25p by 1208 BST. Two of its Coupled Cavity Linac modules are now ready for high-power testing at the company's fac
Read more(ShareCast News) - Advanced Oncotherapy said its partner in the Chinese market, Sinophi Healthcare, recently signed a framework agreement with China-Japan Union Hospital of Jilin University regarding a proton therapy centre. The company, which develops next-generation proton therapy systems for canc
Read more